JavaScript Required

JavaScript is required to use content on this page. Please enable JavaScript in your browser.

Maryland Prescription Drug Affordability Board

The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.

01
11

Upcoming: Prescription Drug Affordability Board Meeting on July 28, 2025

Upcoming: Prescription Drug Affordability Board Meeting on July 28, 2025

In person- Miller Senate Building, Annapolis, MD

Join the Prescription Drug Affordability Board's Mailing List

Join the Prescription Drug Affordability Board's Mailing List

Announcements

Upcoming: Prescription Drug Affordability Board Meeting on July 28, 2025 at 2:00PM. This meeting will be held in person. Please see the Board page for more information.
Please visit the Prescription Drug Affordability Board's, Cost Review Study Process page to view the Dossiers for Farxiga and Jardiance, posted on June 18, 2025. The PDAB is accepting comments through July 3, 2025.
Cost Review Study Process- Request for Information begins May 28th, 2025 for Dupixent and Skyrizi. Please visit the RFI page for more information concerning submissions and technical assistance.
Join the PDAB Mailing List here.

Get Involved

Public Meetings

Board Meetings

Stakeholder Council

Cost Review Study Process

Board Selected Drugs

Report an Affordability Issue

How We Work

Regulations

Fee Assessment Instructions

Quick Links

Reports

News and
Announcements

Contact Us